
![[Banner Image]](images/hprods.gif)
![[Home]](images/bhome.gif)
![[What's New]](images/bnews.gif)
![[Products & Services]](images/bprdsrv.gif)
![[Contents]](images/btoc.gif)
![[Feedback]](images/bfeed.gif)
Sickle Cell Information Center Protocols
by James Eckman, M.D. and Allan Platt, PA-C
Multi-organ System Failure
Acute multiorgan failure syndrome is a severe, life-threatening complication
of pain episodes that may occur in patients with otherwise mild sickle cell
disease. The syndrome appears to be reversed with prompt, aggressive transfusion
therapy. The onset of organ failure was associated with fever,rapid fall in
hemoglobin level and platelet count, nonfocal encephalopathy, and rhabdomyolysis.
Bacterial cultures are negative in most cases. Aggressive transfusion therapy is
associated with survival and with rapid recovery of organ function in most
episodes. The syndrome may develop in patients with previously exhibited
relatively mild disease with little evidence of chronic organ damage and may be
recurrent. High baseline hemoglobin levels may represent a predisposing factor.
Clinical Findings
Subjective Data
Present Illness. Patients with acute multiorgan failure present with
pain that is typical in distribution, but it is unusually severe for the
patient. Deterioration on the third to fourth hospital day is common of therapy
for an acute pain episode.
Past Medical History. Is this pain typical of previous pain episodes?
Usually severe pain must alert the clinician to the potential development of
this complication. Patients with past episodes of acute chest or acute
multiorgan failure may be at higher risk
Objective Data
Physical Examination
- Vital signs. Pulse, blood pressure, temperature, respiratory rate and
quality (shallow, splinting, labored, retraction, accessory muscle use).
- General.
Altered mental status is common at onset.
- HEENT.
Increasing jaundice.
- Neck.
Nucal rigidity.
- Chest.
Check for point tenderness, swelling, erythema, retraction,
asymmetry.
- Lungs.
Percussion and palpation for dullness, increased resonance,
fremitus. Auscultation for rales, wheezes, rhonchi, inspiratory:expiratory
ratio, change in breath sounds, E to A. Listen to cough.
- Heart.
Neck veins for venous pressure and pulse, point of maximum
impulse, thrills, S1, S2, S3, S4, murmur, rubs, edema.
- Abdomen.
Bowel sounds, hepatosplenomegaly, tenderness, rebound, masses.
Subcostal retractions in child.
- Extremities.
Cyanosis, clubbing, edema, calf swelling, calf tenderness,
cords, erythema, pulses.
- Neurologic.
Mental status, cranial nerves, coordination, muscle
strength, sensation.
Laboratory & Imaging studies
- Minimum Evaluation.
CBC with differential, reticulocyte and platelet
count, electrolytes, AST, LDH, Bilirubin total and direct, creatinine, and blood
gases. ECG for patient over 30 years old. Chest x-ray. If sputum production is
present, do smear and culture.
- Acute multiorgan failure is initially heralded by a fall in hemoglobin and
platelet count from baseline. AST,ALT, LDH, direct and total bilirubin and
creatinine become elevated.
- Additional Evaluation.
If chest x-ray is negative and pulmonary
infarction is suspected, consider V/Q lung scan and blood gases. CT or MRI to
evaluate mental status changes. Blood cultures if and lumbar puncture if fever
is present.
Differential Diagnosis
Acute Multiorgan Failure – Defined as the acute deterioration in function
of two of three organ systems: the lung, liver, and kidney. There is often also
deterioration in mental status and evidence of rhabdomyolysis. A fall in
hemoglobin and platelet count form baseline are early manifestations.
Acute Chest Syndrome - defined as a new chest infiltrate in a sickle
cell patient- Etiologies include pneumonia, pulmonary infarction, bone pain from
sickling, bone infarction, and fat embolism.. Differentiation of these disorders
can be very difficult and all occur in high frequency in patients with sickle
syndromes. Fat embolism, pneumonia, and pulmonary infarction cause pleuritic
chest pain, fever, leukocytosis, pulmonary infiltrates, hemoptysis, and hypoxia.
Pulmonary infarctions occur de novo without emboli from phlebitis. Pneumonia is
more likely in children, with high fever, leukocytosis with left shift. Older
children and adults have purulent sputum (younger children swallow theirs).
Chest radiograph often reveals a small pleural effusion. Infarction from
sickling is more common in adults, with hemoptysis, positive V/Q scan with
negative chest x-ray, and in patients without fever or leukocytosis. If in
doubt, always treat for pneumonia. Liver tests and creatinine remain normal.
Drug Overdose - Because of the severity of the pain, the patients
are often receiving high doses of narcotics so initial change in mental status
may be attributed to overdose of medications. Change in the laboratory
parameters notes above and failure to respond to narcan administration support
the diagnosis of multiorgan failure.
Treatment
Transfusion – All patients require immediate, aggressive transfusion
therapy, usually with acute red cell exchange transfusion. Patients with
hemoglobin level of > 7g/dl should primarily be treated with
erythrocytopheresis or manual red cell exchange. If the hemoglobin level is <
7 g/dl and rapidly falling, simple transfusion of packed red cells to maintain a
hemoglobin of 10g/dl may be adequate.
Support – Intensive medical support is required. Narcan is given as a
trial to reverse potential narcotic suppression. Oxygen therapy is indicated for
hypoxia with monitoring by frequent blood gases or continuous transcutaneous
oximetry. Intubation with mechanical ventilation is often required to maintain
adequate oxygenation. Fluids and electrolytes must be used judiciously based on
continuous monitoring of input and output and frequent electrolyte
determinations. Acute dialysis may be required for volume overload or
uncontrollable electrolyte levels.
Antibiotics - Empiric treatment with antibiotics is indicated after
appropriate cultures have been obtained. Third generation cephalosporins with
activity against S. pneumoniae and H. influenzae are good initial choices,
however, penicillin or ampicillin may be appropriate based on sputum smear
findings and local patterns of H. influenzae sensitivity. Empiric addition of a
macrolide antibiotic (erythromycin, azithromycin, or clarithromycin) should also
be considered because Chlamydia and Mycoplasma infections are common. Antibiotic
changes are based on response to therapy and results of cultures and
sensitivities.
Prevention
The prognosis for complete recovery is good if the syndrome is recognized
early and treated aggressively with transfusion support. Patients with pain
episodes that have unusually severe pain should be monitored closely for the
development of acute multiorgan failure. Periodic evaluation of hemoglobin,
platelet counts, bilirubin, creatinine, and CPK especially on the thrid or four
day of the pain episode may increase early recognition. Alteration in mental
status requires prompt, complete evaluation and therapy.
Patient and Parent Education
Patients with previous episodes appear to be at increased risk for future
episodes. Education must include prompt presentation for evaluation of pain
episodes and notifying health professional about past episodes.
References
Hassell KL, Eckman JR, Lane PA Acute multiorgan failure syndrome: a
potentially catastrophiccomplication of severe sickle cell pain episodes. Am J
Med 1994 Feb;96(2):155-62
Athanasou NA et al. Vascular Occlusion and Infarction in Sickle Crisis and
the Sickle Chest Syndrome J. Clin. Path. 38:659, 1985.
Golden C, et al. Acute chest syndrome and sickle cell disease. Curr Opin
Hematol. 1998 Mar; 5(2): 89-92.
Vichinsky EP, et al. Acute chest syndrome in sickle cell disease:clinical
presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997
Mar 1; 89(5): 1787-1792.
Vichinsky E., Williams R, Das M, Earles AN, Lewis N, Adler A, McQuitty J,
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in
sickle cell anemia. Blood, 1994. 83(11): p. 3107-12.
McMahon L., Mark EJ, A 22-year-old man with a sickle cell crisis and sudden
death. N Engl J Med, 1997. 337(18): p. 1293-1301.
![[Home]](images/bhome.gif)
![[What's New]](images/bnews.gif)
![[Products & Services]](images/bprdsrv.gif)
![[Contents]](images/btoc.gif)
![[Feedback]](images/bfeed.gif)
Send mail to aplatt@emory.edu with
questions or comments about this web site.
Copyright © 1997 Sickle Cell Information Center
Last modified: June 08, 2001